Clinical Trial Update: A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer [Phase 2, Phase 3]

View source ↗

Summary

A prospective Phase 2/Phase 3 clinical trial evaluating memantine in patients with cirrhosis and hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatocellular Carcinoma

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: Inova Health Care Services | Conditions: Hepatocellular Carcinoma, Cirrhosis | Phase 2, Phase 3 | Status: RECRUITING